[1]
A. Ghabousian, A. Alizadehasl, N. Ansari, and M. Haghazali, “Potential Ameliorating Role of Spironolactone in Trastuzumab-induced Cardiotoxicity: A Narrative Review”, Int J Med Toxicol Forensic Med, vol. 12, no. 2, p. 36127, Nov. 2021.